Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033

Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033

Including: 1) By Product: Biologics; Biosimilars2) By Source: Mammalian; Non-Mammalian3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC (Quality Check) Studies And PackagingCovering: Catalent Inc.; Cytiva; Rentschler Biopharma; Boehringer Ingelheim GmbH; AGC Biologics Inc.


Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biopharmaceutical contract manufacturing organization (CMO) market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for biopharmaceutical contract manufacturing organization (CMO)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical contract manufacturing organization (CMO) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider biopharmaceutical contract manufacturing organization (CMO) market; and compares it with other markets.

The report covers the following chapters
  • Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by source and by service.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario - The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the biopharmaceutical contract manufacturing organization (CMO) market.
  • Global Market Size and Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by source and by service in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
    • Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
    • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
    • Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
    • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
    • Competitive Dashboard - Briefs on competitive dashboard of major players.
    • Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
    • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
    • Conclusions And Recommendations - This section includes recommendations for biopharmaceutical contract manufacturing organization (CMO) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups..
    • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
    Scope

    Markets Covered:

    1) By Product: Biologics; Biosimilars

    2) By Source: Mammalian; Non-Mammalian

    3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC (Quality Check) Studies; Packaging

    Companies Mentioned: Catalent Inc; Cytiva; Rentschler Biopharma; Boehringer Ingelheim GmbH; AGC Biologics Inc

    Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Canada; France; Germany; UK; Italy; Spain; Russia

    Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

    Time-series: Five years historic and ten years forecast.

    Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biopharmaceutical contract manufacturing organization (CMO) indicators comparison.

    Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

    Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


    1 Executive Summary
    1.1 Biopharmaceutical Contract Manufacturing Organization (CMO) – Market Attractiveness And Macro economic Landscape
    2 Table Of Contents
    3 List Of Tables
    4 List Of Figures
    5 Report Structure
    6 Market Characteristics
    6.1 General Market Definition
    6.2 Summary
    6.3 Biopharmaceutical Contract Manufacturing Organization (CMO) Market Definition And Segmentations
    6.4 Market Segmentation By Product
    6.4.1 Biologics
    6.4.2 Biosimilars
    6.5 Market Segmentation By Source
    6.5.1 Mammalian
    6.5.2 Non-Mammalian
    6.6 Market Segmentation By Service
    6.6.1 Manufacturing
    6.6.2 Fill And Finish Operations
    6.6.3 Analytical And QC Studies
    6.6.4 Packaging
    7 Major Market Trends
    7.1 Increased Merger And Acquisition Activities To Streamline Operations
    7.2 Strategic Partnerships and Collaborations Among Market Players To Drive Innovation
    7.3 Growing Investments To Build New Products And Technologies
    8 Biopharmaceutical Contract Manufacturing Organization (CMO) Market - Macro Economic Scenario
    8.1 COVID-19 Impact On The Biopharmaceutical Contract Manufacturing Organization (CMO) Market
    8.2 Impact Of The War In Ukraine On The Biopharmaceutical Contract Manufacturing Organization (CMO) Market
    8.3 Impact Of High Inflation On The Biopharmaceutical Contract Manufacturing Organization (CMO) Market
    9 Global Market Size and Growth
    9.1 Market Size
    9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
    9.2.1 Market Drivers 2018 – 2023
    9.2.2 Market Restraints 2018 – 2023
    9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
    9.3.1 Market Drivers 2023 – 2028
    9.3.2 Market Restraints 2023 – 2028
    10 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market Segmentation
    10.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.3 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    11 Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Regional and Country Analysis
    11.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    11.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12 Asia-Pacific Market
    12.1 Summary
    12.1.1 Market Overview
    12.1.2 Region Information
    12.1.3 Market Information
    12.1.4 Background Information
    12.1.5 Government Initiatives
    12.1.6 Regulations
    12.1.7 Regulatory Bodies
    12.1.8 Major Associations
    12.1.9 Taxes Levied
    12.1.10 Corporate Tax Structure
    12.1.11 Investments
    12.1.12 Major Companies
    12.2 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.3 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.4 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
    12.6 China Market
    12.7 Summary
    12.7.1 Market Overview
    12.7.2 Country Information
    12.7.3 Market Information
    12.7.4 Background Information
    12.7.5 Government Initiatives
    12.7.6 Regulations
    12.7.7 Regulatory Bodies
    12.7.8 Major Associations
    12.7.9 Taxes Levied
    12.7.10 Corporate Tax Structure
    12.7.11 Investments
    12.7.12 Major Companies
    12.8 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.9 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.10 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.11 India Market
    12.12 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.13 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.14 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.15 Japan Market
    12.16 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.17 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.18 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.19 Australia Market
    12.20 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.21 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.22 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.23 Indonesia Market
    12.24 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.25 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.26 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.27 South Korea Market
    12.28 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.29 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.30 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13 Western Europe Market
    13.1 Summary
    13.1.1 Market Overview
    13.1.2 Region Information
    13.1.3 Market Information
    13.1.4 Background Information
    13.1.5 Government Initiatives
    13.1.6 Regulations
    13.1.7 Regulatory Bodies
    13.1.8 Major Associations
    13.1.9 Taxes Levied
    13.1.10 Corporate Tax Structure
    13.1.11 Investments
    13.1.12 Major Companies
    13.2 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.3 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.4 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.5 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
    13.6 UK Market
    13.7 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.8 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.9 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.10 Germany Market
    13.11 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.12 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.13 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.14 France Market
    13.15 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.16 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.17 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.18 Italy Market
    13.19 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.20 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.21 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.22 Spain Market
    13.23 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.24 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.25 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14 Eastern Europe Market
    14.1 Summary
    14.1.1 Market Overview
    14.1.2 Region Information
    14.1.3 Market Information
    14.1.4 Background Information
    14.1.5 Government Initiatives
    14.1.6 Regulations
    14.1.7 Regulatory Bodies
    14.1.8 Major Associations
    14.1.9 Taxes Levied
    14.1.10 Corporate Tax Structure
    14.1.11 Investments
    14.1.12 Major Companies
    14.2 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.3 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.4 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.5 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
    14.6 Russia Market
    14.7 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.8 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.9 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15 North America Market
    15.1 Summary
    15.1.1 Market Overview
    15.1.2 Region Information
    15.1.3 Market Information
    15.1.4 Background Information
    15.1.5 Government Initiatives
    15.1.6 Regulations
    15.1.7 Regulatory Bodies
    15.1.8 Major Associations
    15.1.9 Taxes Levied
    15.1.10 Corporate Tax Structure
    15.1.11 Investments
    15.1.12 Major Companies
    15.2 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.3 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.4 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.5 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
    15.6 USA Market
    15.7 Summary
    15.7.1 Market Overview
    15.7.2 Country Information
    15.7.3 Market Information
    15.7.4 Background Information
    15.7.5 Government Initiatives
    15.7.6 Regulations
    15.7.7 Regulatory Bodies
    15.7.8 Major Associations
    15.7.9 Taxes Levied
    15.7.10 Corporate Tax Structure
    15.7.11 Investments
    15.7.12 Major Companies
    15.8 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.9 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.10 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.11 Canada Market
    15.12 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.13 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.14 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16 South America Market
    16.1 Summary
    16.1.1 Market Overview
    16.1.2 Region Information
    16.1.3 Market Information
    16.1.4 Background Information
    16.1.5 Government Initiatives
    16.1.6 Regulations
    16.1.7 Regulatory Bodies
    16.1.8 Major Associations
    16.1.9 Taxes Levied
    16.1.10 Corporate Tax Structure
    16.1.11 Investments
    16.1.12 Major Companies
    16.2 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.3 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.4 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.5 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
    16.6 Brazil Market
    16.7 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.8 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.9 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17 Middle East Market
    17.1 Summary
    17.1.1 Market Overview
    17.1.2 Region Information
    17.1.3 Market Information
    17.1.4 Background Information
    17.1.5 Government Initiatives
    17.1.6 Regulations
    17.1.7 Regulatory Bodies
    17.1.8 Major Associations
    17.1.9 Taxes Levied
    17.1.10 Corporate Tax Structure
    17.1.11 Investments
    17.1.12 Major Companies
    17.2 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17.3 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17.4 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18 Africa Market
    18.1 Summary
    18.1.1 Market Overview
    18.1.2 Region Information
    18.1.3 Market Information
    18.1.4 Background Information
    18.1.5 Government Initiatives
    18.1.6 Regulations
    18.1.7 Regulatory Bodies
    18.1.8 Major Associations
    18.1.9 Taxes Levied
    18.1.10 Corporate Tax Structure
    18.1.11 Investments
    18.1.12 Major Companies
    18.2 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18.3 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18.4 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    19 Competitive Landscape And Company Profiles
    19.1 Company Profiles
    19.2 Catalent Inc
    19.2.1 Company Overview
    19.2.2 Products And Services
    19.2.3 Business Strategy
    19.2.4 Financial Overview
    19.3 Cytiva
    19.3.1 Company Overview
    19.3.2 Products And Services
    19.3.3 Business Strategy
    19.3.4 Financial Overview
    19.4 Rentschler Biopharma
    19.4.1 Company Overview
    19.4.2 Products And Services
    19.4.3 Business Strategy
    19.4.4 Financial Overview
    19.5 Boehringer Ingelheim International GmbH
    19.5.1 Company Overview
    19.5.2 Products And Services
    19.5.3 Financial Overview
    19.6 AGC Biologics Inc
    19.6.1 Company Overview
    19.6.2 Products And Services
    19.6.3 Business Strategy
    19.6.4 Financial Overview
    20 Competitive Benchmarking
    21 Competitive Dashboard
    22 Key Mergers And Acquisitions
    22.1 Novo Nordisk Acquired Catalent
    22.2 Advent International And Warburg Pincus Acquired Baxter’s Biopharma Solutions (BPS) Business
    22.3 The Biofarma Group Acquired U.S. Pharma Lab
    22.4 Wacker Chemie Acquired ADL BioPharma
    22.5 Catalent Acquired Metrics Contract Services
    22.6 Bora Pharmaceuticals Acquired Eden Biologics
    22.7 AstraZeneca Acquired Alexion Pharmaceuticals
    23 Opportunities And Strategies
    23.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 – Countries Offering Most New Opportunities
    23.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 – Segments Offering Most New Opportunities
    23.3 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 – Growth Strategies
    23.3.1 Market Trend Based Strategies
    23.3.2 Competitor Strategies
    24 Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Conclusions And Recommendations
    24.1 Conclusions
    24.2 Recommendations
    24.2.1 Product
    24.2.2 Place
    24.2.3 Price
    24.2.4 Promotion
    24.2.5 People
    25 Appendix
    25.1 Geographies Covered
    25.2 Market Data Sources
    25.3 Research Methodology
    25.4 Currencies
    25.5 The Business Research Company
    25.6 Copyright and Disclaimer

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings